Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

September 1971

Volume 183 Myasthenia Gravis

Pages 3–386

    1. MYASTHENIA GRAVIS: PERSPECTIVES (pages 3–4)

      William S. Fields

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30737.x

  1. Part i. correlations between ultrastructures, cytochemistry and function at the synapse

    1. Top of page
    2. Part i. correlations between ultrastructures, cytochemistry and function at the synapse
    3. Part ii. physiology and pharmacology of synaptic transmission
    4. Part iii. pathogenesis and pathophysiology of myasthenia gravis
    5. Part iv. clinical advances in myasthenia gravis
    1. current concepts of synaptic structure and function (pages 5–20)

      George B. Koelle

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30738.x

    1. ORIGIN AND FUNCTION OF SYNAPTIC VESICLES (pages 21–32)

      V. P. Whittaker

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30739.x

    2. ELECTRON MICROSCOPY OF THE IN VITRO DEVELOPMENT OF MAMMALIAN MOTOR END PLATES (pages 33–45)

      G. D. Pappas, E. R. Peterson, E. B. Masurovsky and S. M. Crain

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30740.x

    3. THE SYNDROME OF MYASTHENIA AND POLYMYOSITIS WITH COMMENTS ON THERAPY (pages 64–71)

      T. R. Johns, W. J. Crowley, J. Q. Miller and J. F. Campa

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30742.x

    4. MY ASTHENIA GRAVIS: A NEW HYPOTHESIS OF THE PATHOGENESIS AND A NEW FORM OF TREATMENT (pages 72–87)

      W. King Engel and John R. Warmolts

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30743.x

    5. ULTRASTRUCTURAL ALTERATIONS IN MUSCLE FROM PATIENTS WITH MYASTHENIA GRAVIS AND EATON-LAMBERT SYNDROME (pages 88–122)

      Ronald A. Bergman, Richard J. Johns and Adel K. Afifi

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30744.x

    6. PANEL DISCUSSION (pages 123–130)

      David Grob

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30745.x

  2. Part ii. physiology and pharmacology of synaptic transmission

    1. Top of page
    2. Part i. correlations between ultrastructures, cytochemistry and function at the synapse
    3. Part ii. physiology and pharmacology of synaptic transmission
    4. Part iii. pathogenesis and pathophysiology of myasthenia gravis
    5. Part iv. clinical advances in myasthenia gravis
    1. mechanism of transmitter release from nerve terminals (pages 131–146)

      John I. Hubbard

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30746.x

    1. NEUROMUSCULAR TRANSMISSION OF TROPHIC EFFECTS (pages 158–170)

      Daniel B. Drachman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30748.x

    2. MECHANISMS OF NEUROMUSCULAR BLOCKADE (pages 171–182)

      William L. Nastuk

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30749.x

    3. QUANTAL COMPONENTS OF END-PLATE POTENTIALS IN THE MYASTHENIC SYNDROME (pages 183–199)

      Edward H. Lambert and Dan Elmqvist

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30750.x

    4. PANEL DISCUSSION (pages 200–204)

      William L. Nastuk

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30751.x

  3. Part iii. pathogenesis and pathophysiology of myasthenia gravis

    1. Top of page
    2. Part i. correlations between ultrastructures, cytochemistry and function at the synapse
    3. Part ii. physiology and pharmacology of synaptic transmission
    4. Part iii. pathogenesis and pathophysiology of myasthenia gravis
    5. Part iv. clinical advances in myasthenia gravis
    1. thymus, immunity and autoimmunity (pages 205–220)

      E. J. Yunis, O. Stutman and R. A. Good

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30752.x

    1. LEUKEMIA VIRUS AND AUTOIMMUNE DISEASE OF NZB MICE (pages 221–229)

      Robert C. Mellors

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30753.x

    2. THYMIN: A THYMIC POLYPEPTIDE CAUSING THE NEUROMUSCULAR BLOCK OF MYASTHENIA GRAVIS (pages 230–240)

      Gideon Goldstein and Andrew Manganaro

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30754.x

    3. PANEL DISCUSSION (pages 270–274)

      Otto J. Plescia

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30757.x

  4. Part iv. clinical advances in myasthenia gravis

    1. Top of page
    2. Part i. correlations between ultrastructures, cytochemistry and function at the synapse
    3. Part ii. physiology and pharmacology of synaptic transmission
    4. Part iii. pathogenesis and pathophysiology of myasthenia gravis
    5. Part iv. clinical advances in myasthenia gravis
    1. diagnostic tests in myasthenia gravis: an overview (pages 275–286)

      Francis F. Foldes and Gilbert H. Glaser

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30758.x

    1. ELECTRICAL TESTING IN MYASTHENIA GRAVIS (pages 287–302)

      Coşkun Özdemir and Robert R. Young

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30759.x

    2. RESULTS OF THYMIC (MEDIASTINAL) IRRADIATION IN PATIENTS WITH MYASTHENIA GRAVIS (pages 303–307)

      Milford D. Schulz and Robert S. Schwab

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30760.x

    3. THE ROLE OF THYMECTOMY IN THE TREATMENT OF MYASTHENIA GRAVIS (pages 308–315)

      Vincent P. Perlo, Barry Arnason, David Poskanzer, Benjamin Castleman, Robert S. Schwab, Kermit E. Osserman, Angelo Papatestis, Lawrence Alpert and Alan Kark

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30761.x

    4. GERMINE MONO- AND DIACETATE IN MYASTHENIA GRAVIS (pages 316–333)

      Werner E. Flacke, Robert P. Blume, W. R. Scott, Francis F. Foldes and Kermit E. Osserman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30762.x

    5. THE FAMILIAL OCCURRENCE OF MYASTHENIA GRAVIS (pages 334–350)

      Christian Herrmann Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30763.x

    6. IMMUNOSUPPRESSIVE DRUGS IN TREATMENT OF MYASTHENIA GRAVIS (pages 351–357)

      Lewis P. Rowland

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30764.x

    7. ANTIBIOTIC-INDUCED NEUROMUSCULAR BLOCKADE (pages 358–368)

      Elizabeth A. Wright and Michael P. McQuillen

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30765.x

    8. THE USE OF ACTH AND CORTICOSTEROIDS IN MYASTHENIA GRAVIS (pages 369–374)

      Gabriel Genkins, Peter Kornfeld, Kermit E. Osserman, Tatsuji Namba, David Grob and Norman G. Brunner

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30766.x

    9. PANEL DISCUSSION (pages 375–384)

      Kermit E. Osserman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30767.x

    10. MYASTHENIA GRAVIS: PAST AND FUTURE (pages 385–386)

      Robert S. Schwab

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1971.tb30768.x

SEARCH

SEARCH BY CITATION